ARRS: Density reporting laws not enough to boost breast US

HONOLULU - Rates of breast ultrasound (US) use have slowly trended upward in...Read more on AuntMinnie.comRelated Reading: FDA proposes adding breast density reporting to MQSA Survey says: Breast density laws really do work Patients remain confused about breast density Breast density notification laws boost ultrasound use Rads conflicted about additional dense breast imagingComments: 5/10/2019 4:54:34 AMJan from CT I live in Connecticut, the first State in the Nation to mandate Breast Density reporting to a woman with Dense Breast Tissue as shown on her mammogram. Connecticut Notification law also required an explanation, and encouragement to follow-up her mammogram with a Breast Ultrasound. Living in Connecticut (right time in the right place) saved me from a late-stage breast cancer diagnosis in 2012. The radiology technician at the imaging center gave me "The Talk," and the encouragement to pursue further testing because I had extremely dense breasts. Guess what ? My mammogram was "normal. No suspicious findings." But my immediate follow-up Breast Ultrasound spotted an early invasive cancer. At the time, had I been living in most other states, I would have been clueless, and today dealing with the ravages of end-stage Breast Cancer, or talking to you from the grave. Dissemination of Breast Density information does take time. Years. It takes laws to mandate it, and not all the 37 states have the same wording. Some states tell women, "You...
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Increasing numbers of breast cancer patients receive neoadjuvant chemotherapy (NACT). We seek to investigate whether baseline mammographic and ultrasound features are associated with complete pathological resp...
Source: Cancer Imaging - Category: Radiology Authors: Tags: Research article Source Type: research
ConclusionsThis work has demonstrated a significant correlation between the degree of lesion enhancement in CESM and malignancy. Quantitative analysis of enhancement levels in CESM can distinguish between invasive cancers and benign or in situ lesions.Key Points• There is a possibility of quantitative assessment of contrast enhancement in CESM.• Correlation between quantitative assessment of contrast enhancement in CESM and histopathology was observed.
Source: European Radiology - Category: Radiology Source Type: research
Abstract The detection of lymph node metastasis affects the management of patients with primary breast cancer significantly in terms of staging, treatment, and prognosis. The main goal for the radiologist is to determine and detect the presence of metastatic disease in nonpalpable axillary lymph nodes with a positive predictive value that is high enough to initially select patients for upfront axillary lymph node dissection. Features that are suggestive of axillary adenopathy may be seen with different imaging modalities, but ultrasound is the method of choice for evaluating axillary lymph nodes and for performing...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Oncologist Source Type: research
CONCLUSIONS: Mammography and ultrasound remain the leading modalities in breast imaging among males for diagnostic workup of palpable mass, with gynecomastia being the predominant diagnosis. However, presentation with palpable mass was also associated with malignancy. Despite a notable MBC rate in our cohort, the likelihood of cancer is low in young patients and in cases of gynecomastia. PMID: 31599508 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
You’re staring at a letter from your mammography facility. Your breast exam was normal, great. But then you see a note on the bottom: you have high breast density, which could put you at higher risk for breast cancer in the future. Now what? “The finding of dense breasts on a mammogram can be stressful and confusing for patients,” says Dr. Toni Golen, acting editor in chief of Harvard Women’s Health Watch. It’s information that may concern them, but they don’t know what to do about it. What is breast density? Breasts are composed of: lobules, which produce milk ducts, tubes that carry m...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Breast Cancer Health Tests and procedures Women's Health Source Type: blogs
ConclusionsIn this initial study, CTC was a significant predictor of cancer. The CTC assay can easily be combined with cfDNA to enhance detection rates. Proof-of-concept data suggests potential for a rule out test to avoid unnecessary follow-up/biopsies in BIRADS 3/4 patients.Legal entity responsible for the studyCellMax Life.FundingCellMax Life.DisclosureF. Lin: Shareholder / Stockholder / Stock options: CellMax Life. J. Wu: Shareholder / Stockholder / Stock options: CellMax Life. H.B. Hsieh: Shareholder / Stockholder / Stock options: CellMax Life. S. Chang: Shareholder / Stockholder / Stock options: CellMax Life. M. Jave...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
AbstractBackgroundThe density of tumor-infiltrating lymphocytes (TIL) is a predictive factor for response to neoadjuvant systemic therapy (NAST) in breast cancer. High TIL density correlates with higher complete pathologic remission (pCR) in triple negative and HER2 positive breast cancer. Additionally, not only TIL density but also subsets of immune cells in tumor stroma seem to play an important role in cancer and immune cell interaction and response to chemotherapy. Our aim is to determine TIL density and expression of CD 20, CD3, CD8, PD-L1, FOXP3 and PGM1 on core biopsy specimen and find a correlation with pCR.Trial d...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
The purpose of this study was to investigate the diagnostic performance of the automated breast ultrasound system (ABUS) compared with hand-held ultrasonography (HHUS) and mammography (MG) for breast cancer in women aged 40 y or older. A total of 594 breasts in 385 patients were enrolled in the study. HHUS, ABUS and MG exams were performed for these patients. Follow-up and pathologic findings were used as the reference standard. Based on the reference standard, 519 units were benign or normal and 75 were malignant.
Source: Ultrasound in Medicine and Biology - Category: Radiology Authors: Tags: Original Contribution Source Type: research
ConclusionOur results showed that performing US of the axilla is not justified in screen detected breast cancer patients.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
More News: Breast Cancer | Cancer | Cancer & Oncology | Insurance | Legislation | Mammography | Politics | Radiology | Ultrasound | Women